Citadel Advisors »

Miragen Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $20M 909k 21.78
2023-09-30 $2.1M 137k 15.34
2023-06-30 $3.6M 151k 23.79
2023-03-31 $2.5M 99k 25.44
2022-12-31 $36M 1.2M 29.21
2022-06-30 $12M 1.0M 11.57
2022-03-31 $17M 941k 18.49
2021-12-31 $19M 943k 19.77
2021-03-31 $640k 486k 1.32